Respiratory syncytial virus infections are rapidly becoming a major cause of mortality among children in North America, and is second only to malaria in terms of death of infants up to 1 year old. Despite its high risk on the global population’s health, limited therapeutic options are available to provide relevant treatments.
In addition, people who have suffered from the effects of respiratory syncytial virus infections have been found to be at a greater risk of contracting asthma ... Read more
